2. Academic Validation
  3. CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype

CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype

  • Genet Med. 2018 Aug;20(8):882-889. doi: 10.1038/gim.2017.200.
Lara Rodriguez-Laguna 1,  Kristina Ibañez 2,  Gema Gordo 1 3,  Sixto Garcia-Minaur 3 4,  Fernando Santos-Simarro 3 4,  Noelia Agra 1,  Elena Vallespín 3 5,  Victoria E Fernández-Montaño 5,  Rubén Martín-Arenas 5,  Ángela Del Pozo 2,  Héctor González-Pecellín 5,  Rocío Mena 3 5,  Inmaculada Rueda-Arenas 5,  María V Gomez 5,  Cristina Villaverde 3 6,  Ana Bustamante 3 6,  Carmen Ayuso 3 6,  Víctor L Ruiz-Perez 3 7,  Julián Nevado 3 5,  Pablo Lapunzina 3 4,  Juan C Lopez-Gutierrez 8,  Victor Martinez-Glez 9 10
Affiliations

Affiliations

  • 1 Vascular Malformations Section, Institute of Medical and Molecular Genetics, INGEMM-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • 2 Bioinformatics Section, Institute of Medical and Molecular Genetics, INGEMM-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • 3 CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
  • 4 Clinical Genetics Section, Institute of Medical and Molecular Genetics, INGEMM-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • 5 Structural and Functional Genomics Section, Institute of Medical and Molecular Genetics, INGEMM-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • 6 Department of Genetics, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain.
  • 7 Instituto de Investigaciones Biomédicas "Alberto Sols," CSIC-UAM, Madrid, Spain.
  • 8 Vascular Anomalies Center, Plastic Surgery, Hospital Universitario La Paz, Madrid, Spain. [email protected].
  • 9 Vascular Malformations Section, Institute of Medical and Molecular Genetics, INGEMM-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain. [email protected].
  • 10 CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain. [email protected].
PMID: 29446767 DOI: 10.1038/gim.2017.200
Abstract

Purpose: CLAPO syndrome is a rare vascular disorder characterized by capillary malformation of the lower lip, lymphatic malformation predominant on the face and neck, asymmetry, and partial/generalized overgrowth. Here we tested the hypothesis that, although the genetic cause is not known, the tissue distribution of the clinical manifestations in CLAPO seems to follow a pattern of somatic mosaicism.

Methods: We clinically evaluated a cohort of 13 patients with CLAPO and screened 20 DNA blood/tissue samples from 9 patients using high-throughput, deep sequencing.

Results: We identified five activating mutations in the PIK3CA gene in affected tissues from 6 of the 9 patients studied; one of the variants (NM_006218.2:c.248T>C; p.Phe83Ser) has not been previously described in developmental disorders.

Conclusion: We describe for the first time the presence of somatic activating PIK3CA mutations in patients with CLAPO. We also report an update of the phenotype and natural history of the syndrome.

Keywords

CLAPO; PIK3CA; overgrowth; somatic mosaicism; vascular malformation.

Figures